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Abstract  
Hyperuricemia is significantly associated with increased vascular stiffness  
in asymptomatic healthy Korean women  
Ah Ran Choi  
Department of Medicine 
The Graduate School, Yonsei University 
 
(Directed by Professor Hyeong Cheon Park) 
 
Purpose: Increased serum uric acid is a known risk factor for cardiovascular 
disease. Brachial–ankle pulse wave velocity (baPWV) is a simple index of arterial 
stiffness, while the coronary artery calcium score (CACS) derived from 
multidetector computed tomography is a good marker of coronary atherosclerosis. 
Patients with coronary artery stenosis have significantly elevated baPWV values. 
Therefore, we investigated the relationship between serum uric acid level and 
baPWV in asymptomatic subjects, taking into account confounding factors, 
including CACS. 
Materials and Methods: Of 4894 patients who underwent baPWV measurement 
and coronary computed tomography angiography as part of a general health 
examination at Gangnam Severance Hospital from July 2006 through September 
2013, 2720 healthy subjects were enrolled in this evaluation after exclusion of 
confounding factors. Serum uric acid level was divided into quartiles for men and 
women separately: men, Q1: 1.9–5.2, Q2: 5.21–5.9, Q3: 5.91–6.7, Q4: 6.71–12.1 
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mg/dL; women, Q1: 2.0–3.8, Q2: 3.81–4.3, Q3: 4.31–4.9, Q4: 4.91–8.7 mg/dL. 
High baPWV was defined as ≥1400 cm/s.  
Results: The mean concentration of serum uric acid was found to be significantly 
lower in women than in men (4.37±0.91 vs. 5.94±1.15 mg/dL, p<0.001). Serum 
uric acid was significantly elevated in subjects with a high baPWV. After 
adjustment for age, systolic blood pressure, body mass index, estimated 
glomerular filtration rate, fasting blood sugar, high- and low-density lipoprotein 
cholesterol, smoking habits and CACS, serum uric acid was found to be related 
with high baPWV in women (OR=1.266, 95% CI 1.060–1.512; p=0.009). In 
multivariate logistic regression analysis, Q4 of serum uric acid was independently 
associated with high baPWV in women (OR=1.71, 95% CI 1.089–2.697; p<0.05). 
After adjustment for traditional cardiovascular risk factors and other confounding 
factors including CACS, serum uric acid was independently associated with 
baPWV in women by multiple linear regression analysis (β=10.167, 95% CI 
0.654–19.680; p=0.036). Subgroup analyses showed that, in Korean women of 
median postmenopausal age (>50 years), the highest quartile of serum uric acid 
was associated with high baPWV, after adjustments for other risk factors (OR 
compared with lowest quartile=1.806, 95% CI=1.065–3.063; p=0.028). 
Conclusion: Serum uric acid is associated with aggravation of arterial stiffness in 
healthy Korean women, but not in men. 
 
 
Key words: arterial stiffness, brachial–ankle pulse wave velocity, serum uric acid, 
sex  
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Ah Ran Choi 
Department of Medicine 
The Graduate School, Yonsei University 
 
(Directed by Professor Hyeong Cheon Park) 
 
I. INTRODUCTION  
Elevated serum uric acid levels are a common finding in patients with hypertension, 
metabolic syndrome, and renal disease.1,2 Studies in populations of patients at high risk 
for cardiovascular disease (CVD) have shown an association between high serum uric 
acid levels and CVD.3 Furthermore, some studies have shown that, even in healthy 
populations, high serum uric acid levels were significantly associated with increased 
arterial stiffness.4 Interestingly, a sex-dependent association has been suggested between 
higher serum uric acid level and the risk of adverse cardiovascular (CV) events in healthy 
subjects.5   
Arterial stiffness is an independent risk factor for CV events. Measurement of 
brachial–ankle pulse wave velocity (baPWV) is a noninvasive and simple method for 
determining arterial stiffness.6 Several studies have shown that baPWV is associated with 
CVD and is an independent predictor of CV morbidity and mortality.7,8  
The coronary artery calcium score (CACS) is a good marker of coronary 
atherosclerosis and CV events, and several hospitals in Korea include multidetector 
computed tomography (MDCT) screening for cardiac disease in general health evaluation 
programs. Taking this into account, together with the fact that baPWV values are 
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significantly higher in patients with coronary artery disease than in those without, we 
performed a general health examination including baPWV and MDCT.8  
Although some studies have demonstrated a relationship between serum uric acid level 
and arterial stiffness, they did not exclude confounding factors, such as hypertension, 
diabetes mellitus, chronic kidney disease, gout, coronary artery disease, and 
medications.9-11 Therefore, our study aimed to determine the relationship between serum 
uric acid level and baPWV in healthy subjects, taking into account the confounding 
factors, including CACS. 
   
II. MATERIALS AND METHODS 
1. Study population  
This was a cross-sectional retrospective single-center study. We consecutively collected 
data for 4894 patients who underwent baPWV and coronary computed tomography 
angiography as part of a general health examination at Gangnam Severance Hospital, 
South Korea, from July 2006 through September 2013. The Institutional Review Board of 
Gangnam Severance Hospital, Yonsei University College of Medicine, approved the 
study protocol (IRB no. 3-2015-0128).  
 
2. Measurement of clinical variables and confounding variables   
We reviewed the patients’ medical records, including history of hypertension, diabetes 
mellitus, and smoking status. Height, body weight, and blood pressure were measured 
during hospital visits. Blood samples were obtained on the day of the MDCT scan, after a 
fasting period of at least 12 h, and the following laboratory parameters were determined: 
hemoglobin, calcium, phosphorus, blood urea nitrogen (BUN), creatinine, uric acid, 
fasting blood sugar, cholesterol, triglyceride, low-density lipoprotein (LDL)-cholesterol, 
and high-density lipoprotein (HDL)-cholesterol. Kidney function was determined based 
on estimated glomerular filtration rate (eGFR), which was calculated using the formula 
developed and validated in the Modification of Diet in Renal Disease (MDRD) study12 as 
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follows: eGFR = 186 × serum creatinine–1.154 × age–0.203 (× 0.742, if female).  
Urine protein was determined by the result of a single urine dipstick semiquantitative 
analysis as absent, trace, 1+, 2+, 3+, or 4+. Results recorded as absent or trace were 
defined as the absence of proteinuria. Body mass index (BMI) was calculated as body 
weight (kilograms) divided by the square of height (square meters). Smoking habit was 
classified as current smoker or non-smoker; non-smokers included patients who had 
never smoked and ex-smokers.  
 
3. PWV measurement  
The baPWV was measured using a volume plethysmography device (VP-1000; form 
PWV/ABI, Colin Co., Komaki, Japan) after subjects had rested for at least 5 min. This 
automated device records the phonocardiogram, electrocardiogram, volume pulse form, 
and arterial blood pressure at the left and right brachial arteries and ankles. The baPWV 
was calculated using time-phase analysis between the right brachial artery pressure and 
the volume waveform at both ankles. The distance between the brachium and the ankle 
was calculated automatically according to the subject’s height. After measurement of the 
right and left baPWV, we used the mean baPWV as a marker of arterial stiffness. The 
validity, reliability, and reproducibility of this equipment were demonstrated according to 
previous study methods.13 High baPWV was defined as a value ≥1400 cm/s.7 
 
4. Multi-detector computed tomography (MDCT)  
Subjects were scanned with a cardiac MDCT system (Philips Brilliance 64; Philips 
Medical Systems, Best, The Netherlands) with a 3 mm slice thickness and 1.5 mm 
reconstruction interval. With the patient in the supine position, cardiac MDCT was 
performed in the craniocaudal direction within a single breath-hold at end-inspiratory 
suspension. Patients with an initial heart rate >66 beats/min before cardiac MDCT 
examination received a β-blocker (25 mg atenolol; Tenormin, Hyundai, Seoul, Korea) 
unless β-adrenergic blocking agents were contraindicated. Iodinated contrast agent 
6 
 
(Optiray 350; Tyco Healthcare, Kantata, Canada), at a dose of 2.0 mL/kg not exceeding a 
total of 100 mL, was administered using a two-phase injection protocol for the arterial 
and delayed phases of the CT images. Quantitative calcium scores were calculated 
according to the method previously described by Agatston et al.14 
 
5. Exclusion criteria   
Our study only included participants between the ages of 20 and 80 years. To eliminate 
the influence of confounding variables, subjects with a history of hypertension, diabetes 
mellitus, coronary artery disease, peripheral artery disease, or gout, and those taking 
medications such as allopurinol, febuxostat, colchicine, probenecid, and benzbromarone 
were excluded. In addition, subjects were excluded if they had evidence of chronic kidney 
disease (CKD). The definition of CKD was based on the presence of kidney damage 
(dipstick proteinuria of 1+, 2+, 3+, or 4+), decreased kidney function (eGFR<60 
mL/min/1.73 m2), or diffuse renal disease on abdominal ultrasound. Furthermore, subjects 
with systolic blood pressure (SBP) ≥140 mmHg, diastolic blood pressure (DBP) ≥90 
mmHg, CACS ≥100, or glycosylated hemoglobin (HbA1c) ≥6.5% were excluded. Finally, 
2720 subjects (1477 men, 1243 women) were included in this study (Figure 1). 
 
7 
 
6. Statistical analyses  
All analyses were performed using the Statistical Package for the Social Sciences 
(SPSS, version 20; Chicago, IL, USA). The data are expressed as mean±standard 
deviation (SD) for continuous variables or as percentages for categorical variables. 
Differences between continuous variables were analyzed using the independent t-test and 
the chi-squared test was used to compare categorical variables. Univariate logistic 
regression analyses were used to derive relationships between high baPWV and clinical 
variables. To identify independent factors predicting high baPWV, we used multivariate 
logistic regression analysis to determine odds ratios (OR) and 95% confidence intervals 
(CI). Serum uric acid levels were divided into sex-specific quartiles. The mean baPWV of 
each quartile was analyzed using ANCOVA (analysis of covariance), taking confounding 
factors into account. A single linear regression analysis was also performed to determine 
the relationship between changes in baPWV and clinical values. Multivariate linear 
regression analysis was performed using serum uric acid level as independent risk factor 
with baPWV as dependent factor. A  p-value <0.05 was considered statistically 
significant. 
 
III. RESULTS  
The average age of the study population was 50.7±8.9 years (men, 50.4±8.7 years; 
women, 50.9±9.1 years) and 54.3% of the participants were male. The mean 
concentration of serum uric acid was 5.2±1.3 mg/dL and was found to be significantly 
lower in women (4.37±0.91 mg/dL) than in men (5.94±1.15 mg/dL, p<0.001). Table 1 
shows a comparison of baseline clinical characteristics between subjects divided 
according to sex. Apart from age, all the other parameters—proportion of current smokers, 
SBP, DBP, BMI, eGFR, hemoglobin, BUN, creatinine, fasting plasma glucose, serum uric 
acid, total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, CACS, and mean 
baPWV differed between men and women. Given the difference in their mean serum uric 
acid concentrations, we performed the rest of the analysis separately for men and women.  
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The percentage of subjects with high baPWV (≥1400 cm/s) was 26.6% (n=723). The 
clinical characteristics of men and women according to normal and high baPWV are 
shown in Table 2. There were significant differences in age, SBP, DBP, BMI, eGFR, and 
CACS between the normal and high baPWV groups for both sexes. However, fasting 
plasma glucose, uric acid, total cholesterol, triglyceride, HDL-cholesterol, and LDL-
cholesterol differed significantly between subjects with normal baPWV and those with 
high baPWV only in women, but not in men. 
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Table 3 shows the univariate logistic regression related to the risk of high baPWV. In 
women, age, SBP, DBP, BMI, eGFR, fasting blood sugar, uric acid, total cholesterol, 
triglyceride, HDL-cholesterol, LDL-cholesterol, and CACS correlated significantly with 
high baPWV by univariate logistic analysis. An increase of 1 mg/dL in uric acid level was 
associated with a significant increase in the risk of high baPWV (OR=1.473, 95% CI 
1.28–1.70; p <0.001). After adjusting for age, SBP, BMI, eGFR, fasting blood sugar, 
HDL-cholesterol, LDL-cholesterol, smoking habits and CACS, serum uric acid was 
positively associated with high baPWV in women (OR=1.266, 95% CI 1.060–1.512; 
p=0.009). However, in men, whereas age, smoking, SBP, DBP, BMI, eGFR, and CACS 
correlated significantly with high baPWV, serum uric acid level was not independently 
associated with high baPWV (p=0.157). 
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Serum uric acid levels were divided into sex-specific quartiles as follows: in men, Q1: 
1.9–5.2, Q2: 5.21–5.9, Q3: 5.91–6.7, Q4: 6.71–12.1 mg/dL; in women, Q1: 2.0–3.8, Q2: 
3.81–4.3, Q3: 4.31–4.9, Q4:4.91–8.7 mg/dL. Figure 2 shows a comparison of mean 
baPWV level among participants in each quartile of serum uric acid value according to 
sex. The baPWV in women in the highest quartile of uric acid (Q4) level was 
significantly higher compared to those in the lowest quartile (Q1), whereas no such 
significant association was seen in men (Figure 2).  
The odds ratios for high baPWV were 1.497 (Q3) and 2.33 (Q4) in women (Table 4). 
The results of multivariate adjusted logistic regression analysis are summarized in Table 5.  
After adjusting for age, SBP, BMI, eGFR, fasting blood sugar, HDL-cholesterol, LDL-
cholesterol, smoking habits, and CACS, compared with the lowest quartile of uric acid 
level, only the highest quartile in women was associated with a higher risk of high 
baPWV (OR=1.714, 95% CI 1.089-2.697; p=0.020), whereas in men, serum uric acid 
level was not independently associated with high baPWV (p=1.087).           
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Table 6 shows the coefficients of correlation in linear regression analysis between 
baPWV and other clinical variables in both men and women. This analysis showed that 
age, blood pressure, smoking habit, eGFR, fasting blood sugar, and CACS were related to 
baPWV in men. In women, blood pressure and parameters reflecting either 
atherosclerotic risk factors or metabolic disorder, with the exception of smoking habits, 
correlated with baPWV. Multiple linear regression analysis showed that, after adjustment 
for age, SBP, BMI, smoking, eGFR, fasting blood sugar, HDL-cholesterol, LDL-
cholesterol, CACS, and serum uric acid were independently associated with baPWV only 
in women (Table 7). 
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Since the median age of Korean women at menopause is 50 years,15 we divided the 
women into those less or older than 50 years of age. Fifty-eight point four percent of 
women were older than 50 (n=726). In women aged >50 years, compared with the lowest 
quartile of serum uric acid, the highest quartile was associated with high baPWV after 
adjustment for other risk factors (OR=1.806, 95% CI=1.065–3.063; p=0.028). However, 
for women aged below 50 years the quartiles of serum uric acid level were not related to 
high baPWV (Table 8). 
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IV. DISCUSSION  
Our study found that increased serum uric acid is associated with high baPWV in 
healthy Korean women. Multivariate logistic analysis showed that the risk of high 
baPWV in the highest quartile of uric acid was significantly greater compared to the 
lowest quartile (OR=1.71, 95% CI 1.809–2.697; p=0.020). Further, after adjusting for 
confounding factors, serum uric acid level was linearly and significantly related with 
baPWV in women, but not in men (β=10.167, 95% CI 0.654–19.680; p=0.036).  
Several studies have found a relationship between uric acid level and baPWV in 
healthy subjects. Chen et al.10 showed that uric acid was positively associated with aortic 
stiffness and pressure in Chinese men, but their study failed to exclude confounding 
factors and included subjects with hypertension or diabetes mellitus, as well as those 
taking medication. Shin et al.16 reported a significant relationship between uric acid level 
and arterial stiffness in men, but this relationship was not found in women. They 
explained that this sex-related difference in results was due to the relatively small number 
of women enrolled (n=234). Rather, their results are weak and faulty. Fang et al.5 
demonstrated that a high-normal serum uric acid level or greater is related with increased 
arterial stiffness in healthy women, after adjustment for confounding variables, whereas 
the relationship between higher uric acid and increased arterial stiffness was not 
significant in men. Barbieri et al.17 showed that high uric acid levels are associated with 
severe coronary artery disease only in women. Their findings were similar to ours, and 
this sex-linked difference was also found in other studies, such as the Chicago Heart 
Association Detection Project,18 NHANES I,19 post hoc analysis of the LIFE trials,20 and 
SHHEC study.21 The SHHEC study demonstrated that uric acid level was more strongly 
associated with mortality in women than in men.21 Along similar lines, a higher internal 
carotid artery resistive index22 and an increased risk of silent brain infarction23 have been 
reported in women, but not in men. The fact that this association between serum uric acid 
level and cardiovascular risk factors is closer in women than in men may be related to 
estrogen effects in women. Although elevated serum uric acid in men frequently begins at 
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puberty, hyperuricemia is usually delayed until after menopause in women. Estrogen in 
premenopausal women increases renal clearance of uric acid because of inhibition of 
renal proximal tubular urate reabsorption by organic anion transporters.24 Thus, women 
are more susceptible to serum uric acid-associated vascular injury than are men. Further, 
in cases of elevated serum uric acid, the disease course contributing to the uric acid 
elevation is more serious in women than in men. However, the precise mechanism of this 
association remains to be elucidated.  
Several possible mechanisms have been proposed via which uric acid could affect 
arterial stiffness. First, serum uric acid may promote vascular smooth muscle proliferation, 
cause oxidation of LDL,25 upregulate the expression of platelet-derived growth factor,26 
and stimulate the inflammatory pathways.27,28 In addition, uric acid may exacerbate the 
progression of arterial stiffness by production of reactive oxygen species via the xanthine 
oxidase pathway.29 Another possible reason is that hyperuricemia may cause endothelial 
dysfunction by impairing the generation of nitric oxide in vascular endothelial cells.30  
Although we could not evaluate the menopause status in each individual, we knew that 
the median Korean menopausal age is 50 years.15 In women over the age of 50, compared 
with the lowest quartile of serum uric acid, the highest quartile was associated with high 
baPWV, after adjustments for other risk factors (OR=1.806, 95% CI=1.065–3.063; 
p=0.028). As previous studies demonstrated,31-33 our results suggest that menopause status 
is an important factor influencing arterial stiffness in healthy female subjects. 
Furthermore, Park et al.32 demonstrated that serum uric acid is independently associated 
with vascular stiffness in Korean postmenopausal women. Yu et al.33 reported that 
hyperuricemia was associated with left ventricular hypertrophy only in postmenopausal 
women in the general population, but not in premenopausal women. One previous study 
observed that the incidence of CVD in women increased with age, especially in 
postmenopausal women.34 Our data are consistent with those of the previous studies,32-34 
as we found that serum uric acid was an essential independent factor related with arterial 
stiffness in postmenopausal women. There is a lesser rise in uric acid in postmenopausal 
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women treated with hormone replacement therapy and some studies demonstrated that 
estrogen has beneficial effects on arterial stiffness.35,36 Regarding the mechanism of 
hyperuricemia in postmenopausal women, it has been suggested that endogenous 
estradiol could play a specific protective role against CVD, resulting in the weak 
relationship between hyperuricemia and high baPWV in premenopausal women. 
Endogenous ovarian hormones, such as estradiol, exert an antioxidant effect on 
atherosclerosis, but this effect of estrogen disappears after menopause.37 Further 
investigation is required to establish a possible mechanism for this phenomenon.  
It is well known that baPWV increases with age,31,38 hypertension,39 diabetes,40 and 
CKD.41-43 Therefore, we excluded these confounding factors that cause increased baPWV. 
We adopted a study design that controlled for renal function, past medical history 
(hypertension, diabetes), and medications (uric acid-lowering agents). In addition, the 
assessment of renal abnormalities was based on the detection of proteinuria, the MDRD 
equation, and ultrasound renal imaging findings. Since proteinuria is an early and 
sensitive marker of kidney damage, we used proteinuria detected by dipstick urinalysis as 
a marker of kidney damage. We paid careful attention to the definition of healthy subjects 
by excluding those with proteinuria of 1+ or more on dipstick urine analysis.  
In this study, the CACS was measured in all subjects using cardiac MDCT. It has been 
shown that patients with significant coronary artery stenosis have significantly high 
baPWV.44 It has been proposed that a CACS of over 100 indicates the presence of 
atherosclerosis,45 so we excluded subjects with CACS>100. In our study, baPWV showed 
a graded increase according to the CACS value in both sexes. Therefore, we considered 
CACS as a confounding factor. After adjustment for traditional confounding factors as 
well as for CACS, serum uric acid was independently associated with arterial stiffness.  
We defined high baPWV as a level ≥1400 cm/s. As our study was focused on healthy 
subjects, a baPWV≥1400 cm/s was taken as an indicator of increased arterial stiffness.7 
This cutoff value corresponds to a moderate Framingham risk score and represents the 
threshold at which the risk for incident hypertension also increases in normotensive 
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individuals. In addition, this value is considered a moderate-risk threshold at which 
lifestyle modification is recommended.  
In our study, age and increased blood pressure were independently associated with 
increased arterial stiffness, and these results are compatible with former assessments.9,16,31 
Our study showed that hyperglycemia was associated with a higher risk of high baPWV 
in women, but not in men, and this result is consistent with previous findings of a greater 
association between insulin resistance and arterial stiffness in women than men.35,46 
Previous studies32,47,48 demonstrated that the insulin resistance index and homeostatic 
model assessment of insulin resistance (HOMA-IR) was correlated with serum uric acid 
level.  
Our results showed that current smoking was significantly associated with increased 
arterial stiffness in men, but not in women. This lack of association between smoking 
habits and increased arterial stiffness in women might have been due to the small number 
of women categorized as smokers (n=34).  
There is no universally accepted definition of hyperuricemia. Nevertheless, the 
reference range of serum uric acid is based on its variation among healthy individuals: 
frank hyperuricemia is defined as >6 mg/dL in women and >7 mg/dL in men.49 The 
relationship between uric acid and CVD is observed not only with definite hyperuricemia, 
but also with a high-normal serum uric acid level range (>5.2 to 5.5 mg/dL) in healthy 
individuals.5,16,32 In our study, according to the odds ratio linking serum uric acid with 
high baPWV, arterial stiffness may be occurring above the fourth quartile (4.91–8.7 
mg/dL) group in women. In women, serum uric acid above the threshold of 4.91 mg/dL 
belongs to the normal range for this substance. However, Akkineni et al.50 recently 
reported that treatment of asymptomatic hyperuricemia with allopurinol prevented 
vascular events in adults. Their study model predicts that treating asymptomatic 
hyperuricemia with allopurinol is most effective in preventing vascular events at a serum 
uric acid level above 7.0 mg/dL in men and 5.0 mg/dL in women. Therefore, the cutoff 
range of serum uric acid used in our study was reasonable.  
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This study had several limitations. First, as it was cross-sectional we could not 
demonstrate a causal relationship between serum uric acid level and increased arterial 
stiffness. Second, we cannot exclude the possibility that our findings were influenced by 
dietary intake of uric acid supplements and an insufficient history of medications. Certain 
dietary habits,51 meat or seafood intake, and alcohol consumption are associated with a 
higher prevalence of hyperuricemia.52 In addition, our database did not include 
information on the patients’ history of diuretic or statin use. Third, proteinuria was 
evaluated with the dipstick method in this study. This method can only semiquantify the 
degree of proteinuria and cannot detect microalbuminuria. However, this process has 
been used widely in general health examination screening, and its usability and reliability 
have been verified.53 Fourth, we used baPWV instead of carotid–femoral PWV (cfPWV). 
The prognostic value of baPWV is lower than that of cfPWV. However, recent studies 
have shown that baPWV is associated with both central and peripheral PWVs,54 and is 
useful as a surrogate marker for various cardiovascular risk factors, as well as for 
cfPWV.6,13,55,56 In addition, as previously stated, baPWV is easy to measure and is suitable 
for routine clinical use in healthy subjects. Finally, the study subjects were confined to the 
Korean population and any extrapolation of our results to the general population should 
be viewed with caution. 
 
V. CONCLUSION  
We found that serum uric acid is associated with increased arterial stiffness in healthy 
Korean women, but not men. The related mechanisms and possible causal effect of serum 
uric acid on arterial stiffness warrant further research. 
 
 
 
 
 
19 
 
REFERENCES  
1. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident 
hypertension: a systematic review and meta-analysis. Arthritis Care Res 
(Hoboken) 2011;63:102-10. 
2. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia 
and coronary heart disease: a systematic review and meta-analysis. Arthritis Care 
Res (Hoboken) 2010;62:170-80. 
3. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and 
cardiovascular disease: recent developments, and where do they leave us? Am J 
Med 2005;118:816-26. 
4. Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for 
subclinical coronary atherosclerosis--data from a prospective observational 
cohort study. Arthritis Res Ther 2011;13:R66. 
5. Fang JI, Wu JS, Yang YC, Wang RH, Lu FH, Chang CJ. High uric acid level 
associated with increased arterial stiffness in apparently healthy women. 
Atherosclerosis 2014;236:389-93. 
6. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial 
ankle pulse wave velocity measurements in hypertensive patients. Am J 
Hypertens 2003;16:653-7. 
7. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. 
Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular 
damage and cardiovascular risk. Hypertens Res 2003;26:615-22. 
8. Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, et al. High brachial-
ankle pulse wave velocity is an independent predictor of the presence of coronary 
artery disease in men. Hypertens Res 2004;27:71-8. 
9. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong YY, et al. 
Relationships of C-reactive protein, uric acid, and glomerular filtration rate to 
arterial stiffness in Japanese subjects. J Hum Hypertens 2005;19:907-13. 
20 
 
10. Chen X, Li Y, Sheng CS, Huang QF, Zheng Y, Wang JG. Association of serum 
uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J 
Hypertens 2010;23:387-92. 
11. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Higher 
serum uric acid is associated with increased arterial stiffness in Japanese 
individuals. Atherosclerosis 2007;192:131-7. 
12. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured 
and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83. 
13. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, 
reproducibility, and clinical significance of noninvasive brachial-ankle pulse 
wave velocity measurement. Hypertens Res 2002;25:359-64. 
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. 
Quantification of coronary artery calcium using ultrafast computed tomography. J 
Am Coll Cardiol 1990;15:827-32. 
15. Young-Joo Park HSK, Hyun-Choel Kang. The Age at menopause and related 
factors in Korean Women. Journal of Korean  Academy of Nursing 
2002;32:1024-31. 
16. Shin JY, Lee HR, Shim JY. Significance of high-normal serum uric acid level as a 
risk factor for arterial stiffness in healthy Korean men. Vasc Med 2012;17:37-43. 
17. Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G. Impact 
of sex on uric acid levels and its relationship with the extent of coronary artery 
disease: A single-centre study. Atherosclerosis 2015;241:241-8. 
18. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid 
and 11.5-year mortality of middle-aged women: findings of the Chicago Heart 
Association Detection Project in Industry. J Clin Epidemiol 1989;42:257-67. 
19. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the 
NHANES I epidemiologic follow-up study, 1971-1992. National Health and 
Nutrition Examination Survey. Jama 2000;283:2404-10. 
21 
 
20. Daskalopoulou SS, Athyros VG, Elisaf M, Mikhailidis D. The impact of serum 
uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 
2004;66:1714-5. 
21. Juraschek SP, Tunstall-Pedoe H, Woodward M. Serum uric acid and the risk of 
mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort 
Study. Atherosclerosis 2014;233:623-9. 
22. Cipolli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhaes JA, Bellinazzi VR, 
Matos-Souza JR, et al. Relationship between serum uric acid and internal carotid 
resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc 
Disord 2012;12:52. 
23. Heo SH, Lee SH. High levels of serum uric acid are associated with silent brain 
infarction. J Neurol Sci 2010;297:6-10. 
24. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt 
G, et al. Rat renal cortical OAT1 and OAT3 exhibit gender differences 
determined by both androgen stimulation and estrogen inhibition. Am J Physiol 
Renal Physiol 2004;287:F124-38. 
25. Schlotte V, Sevanian A, Hochstein P, Weithmann KU. Effect of uric acid and 
chemical analogues on oxidation of human low density lipoprotein in vitro. Free 
Radic Biol Med 1998;25:839-47. 
26. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell 
proliferation by increasing platelet-derived growth factor A-chain expression. J 
Biol Chem 1991;266:8604-8. 
27. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid 
stimulates monocyte chemoattractant protein-1 production in vascular smooth 
muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. 
Hypertension 2003;41:1287-93. 
28. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al. Relationship 
of serum uric acid to measures of endothelial function and atherosclerosis in 
22 
 
healthy adults. Int J Clin Pract 2005;59:1276-82. 
29. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in 
preeclampsia, revisited. Am J Obstet Gynecol 1996;174:288-91. 
30. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. 
Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42. 
31. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. 
Influences of age and gender on results of noninvasive brachial-ankle pulse wave 
velocity measurement--a survey of 12517 subjects. Atherosclerosis 
2003;166:303-9. 
32. Park JS, Kang S, Ahn CW, Cha BS, Kim KR, Lee HC. Relationships between 
serum uric acid, adiponectin and arterial stiffness in postmenopausal women. 
Maturitas 2012;73:344-8. 
33. Yu S, Yang H, Guo X, Zheng L, Sun Y. Hyperuricemia is independently 
associated with left ventricular hypertrophy in post-menopausal women but not in 
pre-menopausal women in rural Northeast China. Gynecol Endocrinol 
2015;31:736-41. 
34. Yousefzadeh G, Mahdavi-Jafari F, Shokoohi M, Najafipour H, Haghdoost AA, 
Modares-Nejad V. Modulation of coronary artery disease risk factors by 
menopausal status: A population based study among Iranian women 
(KERCADRStudy). ARYA Atheroscler 2013;9:332-6. 
35. Hayward CS, Knight DC, Wren BG, Kelly RP. Effect of hormone replacement 
therapy on non-invasive cardiovascular haemodynamics. J Hypertens 
1997;15:987-93. 
36. Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and 
hormone replacement on cardiovascular function. Cardiovasc Res 2000;46:28-49. 
37. Doshi SB, Agarwal A. The role of oxidative stress in menopause. J Midlife 
Health 2013;4:140-6. 
38. Fujiwara Y, Chaves P, Takahashi R, Amano H, Kumagai S, Fujita K, et al. 
23 
 
Relationships between brachial-ankle pulse wave velocity and conventional 
atherosclerotic risk factors in community-dwelling people. Prev Med 
2004;39:1135-42. 
39. Yamashina A, Tomiyama H, Arai T, Koji Y, Yambe M, Motobe H, et al. 
Nomogram of the relation of brachial-ankle pulse wave velocity with blood 
pressure. Hypertens Res 2003;26:801-6. 
40. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, et al. Pulse wave 
velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno 
and Sobetsu study. Diabetes Care 2003;26:437-40. 
41. Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S. Increased pulse wave 
velocity is associated with low creatinine clearance and proteinuria in a screened 
cohort. Am J Kidney Dis 2006;47:790-7. 
42. Tomiyama H, Tanaka H, Hashimoto H, Matsumoto C, Odaira M, Yamada J, et al. 
Arterial stiffness and declines in individuals with normal renal function/early 
chronic kidney disease. Atherosclerosis 2010;212:345-50. 
43. Chen SC, Chang JM, Liu WC, Tsai YC, Tsai JC, Hsu PC, et al. Brachial-ankle 
pulse wave velocity and rate of renal function decline and mortality in chronic 
kidney disease. Clin J Am Soc Nephrol 2011;6:724-32. 
44. Xu Y, Wu Y, Li J, Ma W, Guo X, Luo Y, et al. The predictive value of brachial-
ankle pulse wave velocity in coronary atherosclerosis and peripheral artery 
diseases in urban Chinese patients. Hypertens Res 2008;31:1079-85. 
45. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al. 
Assessment of coronary artery disease by cardiac computed tomography: a 
scientific statement from the American Heart Association Committee on 
Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology 
and Intervention, and Committee on Cardiac Imaging, Council on Clinical 
Cardiology. Circulation 2006;114:1761-91. 
46. Hayward CS, Samaras K, Campbell L, Kelly RP. Effect of combination hormone 
24 
 
replacement therapy on ambulatory blood pressure and arterial stiffness in 
diabetic postmenopausal women. Am J Hypertens 2001;14:699-703. 
47. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship 
between serum uric acid concentration and insulin resistance and metabolic 
syndrome. Circ J 2005;69:928-33. 
48. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between 
serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese 
individuals. Arterioscler Thromb Vasc Biol 2005;25:1038-44. 
49. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 
2008;359:1811-21. 
50. Akkineni R, Tapp S, Tosteson AN, Lee A, Miller KL, Choi HK, et al. Treatment 
of asymptomatic hyperuricemia and prevention of vascular disease: a decision 
analytic approach. J Rheumatol 2014;41:739-48. 
51. Li X, Song P, Li J, Wang P, Li G. Relationship between hyperuricemia and 
dietary risk factors in Chinese adults: a cross-sectional study. Rheumatol Int 2015; 
doi:10.1007/s00296-015-3315-0. 
52. Xiong Z, Zhu C, Qian X, Zhu J, Wu Z, Chen L. Serum uric acid is associated 
with dietary and lifestyle factors in elderly women in suburban Guangzhou in 
Guangdong province of south China. J Nutr Health Aging 2013;17:30-4. 
53. Davidson MB, Smiley JF. Relationship between dipstick positive proteinuria and 
albumin:creatinine ratios. J Diabetes Complications 1999;13:52-5. 
54. Choo J, Shin C, Barinas-Mitchell E, Masaki K, Willcox BJ, Seto TB, et al. 
Regional pulse wave velocities and their cardiovascular risk factors among 
healthy middle-aged men: a cross-sectional population-based study. BMC 
Cardiovasc Disord 2014;14:5. 
55. Xiong Z, Zhu C, Zheng Z, Wang M, Wu Z, Chen L, et al. Relationship between 
arterial stiffness assessed by brachial-ankle pulse wave velocity and coronary 
artery disease severity assessed by the SYNTAX score. J Atheroscler Thromb 
25 
 
2012;19:970-6. 
56. Kawai T, Ohishi M, Onishi M, Ito N, Takeya Y, Oguro R, et al. Prognostic impact 
of regional arterial stiffness in hypertensive patients. Heart Vessels 2015;30:338-
46. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
ABSTRACT (IN KOREAN) 
무증상의 한국 여성에서 고요산혈증이 혈관 경직도에 미치는 영향 
<지도교수 박 형 천> 
연세대학교 대학원 의학과 
최아란 
최근 건강검진 목적으로 일반 혈액생화학 검사뿐 아니라 비 침습적인 
방법인 상완 발목 맥파 속도를 이용한 혈관 경직도, 관상동맥 혈관촬영 
CT를 이용한 관상 동맥 석회화가 포함되기도 한다. 혈청 요산과 심혈
관계질환에 대해서는 많은 논문에서 그 연관성에 대해 입증하고 있으며 
최근 일부 연구에는 무증상의 환자에서도 그 연관성에 대하여 보고하고 
있다. 본 논문은 무증상의 건강검진을 받은 성인을 대상으로 혈청 요산 
수치와 혈관 경직도의 관련성에 대해 연구하고자 하였다. 발목 맥박 파 
전파속도에 영향을 줄 수 있는 다양한 임상변수들과 관상동맥 석회화 
수치가 높을수록 발목 맥박 파 전파속도도 높은 점을 감안하여 이를 혼
란 변수로 포함시켰다. 요산 수치는 남성과 여성에서 통계학적으로 차
이가 보여 남성과 여성으로 분리하였으며 요산수치를 각각 4사분위로 
구분하였다. 다양한 인자를 보정한 이후에도 이분형 회귀분석 및 선형 
회귀 분석에서 혈청 요산 수치는 혈관 경직도와 의미 있는 상관관계를 
가지고 있음을 확인하였다. 이러한 요산과 혈관 경직도의 관계는 여성
에서 뚜렷하게 나타났지만 남성에서는 연관성이 없었다. 또한 한국 여
성의 폐경기 나이 중앙값을 기준으로 하였을 때 폐경기 여성에서 요산 
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수치가 혈관 경직도에 통계학적으로 영향을 주는 것으로 나타났다.  본 
연구는 무증상의 여성 건강 검진 환자에서 혈청 요산이 혈관 경직도와 
연관성이 있다는 것을 보고 하였다.  
 
 
 
 
 
 
 
 
 
 
 
 
 
핵심 되는 말: 동맥 경직, 맥박 파 전파 속도, 요산, 성별  
